News

The German Quality and Finance Institute published the results of the research entitled "Champions of Growth": the aim was rewarding the 400 companies whose turnover increased most in the three-year period 2016-2019.

The Food and Drug Administration has granted the Pediatric Orphan Drug Designation to the inhaled formulation of Teicoplanin for patients with Cystic Fibrosis.

Neupharma, one of the finalists for the category "Companies - Health & Pharma" from “Le Fonti Awards”, wins the title "Excellence of the Year - Innovation & Leadership - Medical Devices for Cystic Fibrosis"

The new area of the website “DM PARI Service” is online and ready to be consulted

May 7, 2020: NEUPHARMA 2020 SITE IS ONLINE

Imola, 4 May 2020: Imola Red Cross continues a constant activity to face COVID-19 emergency thanks to the community aids.

Imola, November 2019: Neupharma is proud to have joined this important life-saving initiative for our community

Imola, 02 September 2019: Neupharma inaugurates the new corporate headquarters in the city centre of Imola.

On 19 June 2019, Neupharma Members collected the prestigious Industria Felix award. The ceremony was organized by the homonymous Cultural Association in collaboration with the CERVED Centre of Economic Studies, and it was held at the LUISS Guido Carli University of Rome.